Nuvation Bio Inc.

This study tested a daily pill called AB-106 in people whose solid tumors had spread and carried a specific gene change (NTRK fusion). The goal was to see if the drug could shrink tumors. The trial was stopped early and included only 14 participants who had already tried other tr…

This study tested a new drug called NUV-868, alone or with other cancer drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The trial was stopp…